MedPal AI plc (AIM: MPAL; FRA: Z1N) has reported strong October trading, with group revenue climbing to approximately £4.1 million as its New Health weight management business recorded a sharp
MedPal AI reports 42,500 customers as Mounjaro business grows
MedPal AI plc (AIM: MPAL) has announced that its New Health business has become one of the UK’s top 30 Mounjaro providers by supply volume, climbing from 3,048th to 29th
MedPal AI Says No Equity Raise Planned as Orders Hit Record and £8m Facility Talks Advance
MedPal AI plc (AIM: MPAL; FRA: Z1N) has issued a trading and financing update following sharp movements in its share price and trading volumes.
MedPal AI September Revenue Hits £3.2m as Annualised Run Rate Tops £38m
MedPal AI plc (AIM: MPAL; FRA: Z1N) reported another sharp increase in trading during September, with Group revenue reaching £3.2 million.
MedPal AI Strengthens Board as £28m Revenue Run Rate Drives Growth Incentive Package
MedPal AI plc (AIM: MPAL; FRA: Z1N) has appointed former eEnergy Group chief executive Harvey Sinclair as an independent non-executive director as the digital health group looks to strengthen its
MedPal AI plc – From zero to £28 million annualised in ten months
MedPal AI plc (AIM: MPAL) has reported a sharp acceleration in trading, with its New Health GLP-1 weight-management business generating £1.83 million of revenue in August, an increase of more
Mounjaro wins US approval to cut heart attack and stroke risk
MedPal AI plc (AIM: MPAL) has highlighted the potential expansion of the GLP-1 market after the US Food and Drug Administration approved Eli Lilly’s Mounjaro to reduce the risk of
MedPal highlights new UK oral weight-loss treatment
MedPal AI plc (AIM: MPAL) has highlighted the UK approval of Eli Lilly’s once-daily oral GLP-1 treatment, Foundayo, which has been authorised for weight loss and weight maintenance in eligible
MedPal AI Connects Pharmacy, Private Care and Software in a Rapid Growth Strategy
MedPal’s (AIM: MPAL) July trading update gave investors the clearest indication yet that its digital-health ambitions are being supported by real operating revenue. The company reported an annualised recurring revenue
Zak Mir Speaks to MedPal AI CEO Jason Drummond
Zak Mir talks to Jason Drummond, CEO of Medpal (AIM: MPAL), as the AI-native digital health and pharmacy group provided a trading update for July 2026, the first month in
MedPal AI Revenue Surges Above £8.6 Million After Record July
MedPal AI PLC (AIM: MPAL) shares rose 19% after the AI-powered digital health company reported a record July, with all three of its recurring revenue streams contributing to growth for
MedPal AI Acquires eMARx to Expand Care Home Medication Platform
MedPal AI (AIM: MPAL) has acquired Solid State Technologies, trading as eMARx, in a deal designed to complete its digital medication platform for the UK care home market.